| Kalie R Mccauley, CNP | |
|
6300 Wedgwood Rd N, Maple Grove, MN 55311-3647 | |
| (612) 244-5325 | |
| Not Available |
| Full Name | Kalie R Mccauley |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 6300 Wedgwood Rd N, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063010304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 7673 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healthstar Home Health | North saint paul, MN | Home health agency |
| Grand Itasca Clinic & Hosp Homecare | Grand rapids, MN | Home health agency |
| Grand Itasca Clinic And Hospital | Grand rapids, MN | Hospital |
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grand Itasca Clinic And Hospital | 8123939550 | 115 |
News Archive
The eyes may or may not be windows to the soul, as the old adage goes, but scientists are reporting evidence that a peek into the eyes of cattle may become the basis for a long sought test to detect infection with the agent that causes Mad Cow Disease. That test could help prevent the disease from spreading in the food supply. A study on using the tell-tale glow given off by eyes infected with the Mad Cow agent appears in ACS' semi-monthly journal Analytical Chemistry.
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.
Pulmatrix today announced the successful completion and positive results of the first part of a two-part Phase IB clinical study in chronic obstructive pulmonary disease (COPD) patients with their lead clinical candidate PUR0200.
Coventry Health Care of Florida is first to the greater Tampa market with a portfolio of hybrid PPO health care plans that blend the best features of traditional co-pay based plans with the freedom and affordability of consumer-directed plans.
› Verified 2 days ago
| Entity Name | Grand Itasca Clinic And Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669426631 PECOS PAC ID: 8123939550 Enrollment ID: O20031105000209 |
News Archive
The eyes may or may not be windows to the soul, as the old adage goes, but scientists are reporting evidence that a peek into the eyes of cattle may become the basis for a long sought test to detect infection with the agent that causes Mad Cow Disease. That test could help prevent the disease from spreading in the food supply. A study on using the tell-tale glow given off by eyes infected with the Mad Cow agent appears in ACS' semi-monthly journal Analytical Chemistry.
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.
Pulmatrix today announced the successful completion and positive results of the first part of a two-part Phase IB clinical study in chronic obstructive pulmonary disease (COPD) patients with their lead clinical candidate PUR0200.
Coventry Health Care of Florida is first to the greater Tampa market with a portfolio of hybrid PPO health care plans that blend the best features of traditional co-pay based plans with the freedom and affordability of consumer-directed plans.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kalie R Mccauley, CNP 6300 Wedgwood Rd N, Maple Grove, MN 55311-3647 Ph: (612) 244-5325 | Kalie R Mccauley, CNP 6300 Wedgwood Rd N, Maple Grove, MN 55311-3647 Ph: (612) 244-5325 |
News Archive
The eyes may or may not be windows to the soul, as the old adage goes, but scientists are reporting evidence that a peek into the eyes of cattle may become the basis for a long sought test to detect infection with the agent that causes Mad Cow Disease. That test could help prevent the disease from spreading in the food supply. A study on using the tell-tale glow given off by eyes infected with the Mad Cow agent appears in ACS' semi-monthly journal Analytical Chemistry.
Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.
Pulmatrix today announced the successful completion and positive results of the first part of a two-part Phase IB clinical study in chronic obstructive pulmonary disease (COPD) patients with their lead clinical candidate PUR0200.
Coventry Health Care of Florida is first to the greater Tampa market with a portfolio of hybrid PPO health care plans that blend the best features of traditional co-pay based plans with the freedom and affordability of consumer-directed plans.
› Verified 2 days ago
Gregory Njora Kariuki, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10150 Niagara Ln N # 100, Maple Grove, MN 55369 Phone: 763-712-2100 | |
Kayla Joyer, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9645 Grove Cir N Ste 100, Maple Grove, MN 55369 Phone: 763-302-4114 | |
Rhonda Marie Wolfe, MSN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6300 Wedgwood Rd N, Maple Grove, MN 55311 Phone: 866-389-2727 | |
Pennelope H Fearing, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9550 Upland Ln N Ste 100, Maple Grove, MN 55369 Phone: 763-772-9820 Fax: 763-537-6666 | |
Mr. Abolfazl Kowsari, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9512 Pineview Ln N, Maple Grove, MN 55369 Phone: 763-923-5608 | |
Jill E Gauger, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 7368 Kirkwood Ct N, Maple Grove, MN 55369 Phone: 763-416-2280 |